State Street
LUMO

State Street’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

State Street’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,237
Closed -$43.5K – 4337
2024
Q3 		$43.5K Hold
11,237
– – ﹤0.01% 4122
2024
Q2 		$26.1K Hold
11,237
– – ﹤0.01% 4246
2024
Q1 		$31.7K Hold
11,237
– – ﹤0.01% 4236
2023
Q4 		$35.2K Hold
11,237
– – ﹤0.01% 4259
2023
Q3 		$37.1K Hold
11,237
– – ﹤0.01% 4347
2023
Q2 		$37.1K Hold
11,237
– – ﹤0.01% 4492
2023
Q1 		$38.1K Hold
11,237
– – ﹤0.01% 4571
2022
Q4 		$40.6K Hold
11,237
– – ﹤0.01% 4605
2022
Q3 		$99K Hold
11,237
– – ﹤0.01% 4471
2022
Q2 		$87K Hold
11,237
– – ﹤0.01% 4578
2022
Q1 		$106K Hold
11,237
– – ﹤0.01% 4622
2021
Q4 		$78K Hold
11,237
– – ﹤0.01% 4622
2021
Q3 		$107K Hold
11,237
– – ﹤0.01% 4531
2021
Q2 		$112K Buy
+11,237
New +$125K ﹤0.01% 4336
2020
Q1 		– Sell
-2,905
Closed -$66K – 3801
2019
Q4 		$66K Hold
2,905
– – ﹤0.01% 3706
2019
Q3 		$42K Hold
2,905
– – ﹤0.01% 3730
2019
Q2 		$39K Sell
2,905
-55,602
-95% -$840K ﹤0.01% 3737
2019
Q1 		$1.02M Buy
58,507
+656
+1% +$9.78K ﹤0.01% 3337
2018
Q4 		$791K Sell
57,851
-2,129
-4% -$37.5K ﹤0.01% 3370
2018
Q3 		$1.29M Buy
59,980
+7,342
+14% +$223K ﹤0.01% 3362
2018
Q2 		$2.25M Sell
52,638
-2,417
-4% -$111K ﹤0.01% 3209
2018
Q1 		$3.59M Buy
55,055
+6,989
+15% +$495K ﹤0.01% 2937
2017
Q4 		$3.51M Buy
48,066
+2,546
+6% +$211K ﹤0.01% 2953
2017
Q3 		$4.16M Buy
45,520
+2,024
+5% +$155K ﹤0.01% 2883
2017
Q2 		$2.88M Buy
43,496
+514
+1% +$63.6K ﹤0.01% 2986
2017
Q1 		$9.32M Sell
42,982
-4,843
-10% -$692K ﹤0.01% 2406
2016
Q4 		$4.42M Buy
47,825
+2,558
+6% +$288K ﹤0.01% 2760
2016
Q3 		$6.13M Buy
45,267
+1,248
+3% +$124K ﹤0.01% 2446
2016
Q2 		$4.46M Sell
44,019
-83,436
-65% -$10.3M ﹤0.01% 2650
2016
Q1 		$20.9M Buy
127,455
+22,500
+21% +$4.56M ﹤0.01% 1694
2015
Q4 		$34.4M Buy
104,955
+7,710
+8% +$2.51M ﹤0.01% 1372
2015
Q3 		$31.4M Sell
97,245
-7,672
-7% -$3.37M ﹤0.01% 1440
2015
Q2 		$41.8M Buy
104,917
+18,463
+21% +$7.85M ﹤0.01% 1373
2015
Q1 		$42.6M Sell
86,454
-7,332
-8% -$2.84M ﹤0.01% 1337
2014
Q4 		$33.6M Sell
93,786
-5,136
-5% -$1.53M ﹤0.01% 1445
2014
Q3 		$19.1M Sell
98,922
-1,202
-1% -$264K ﹤0.01% 1781
2014
Q2 		$23.9M Buy
100,124
+5,616
+6% +$1.14M ﹤0.01% 1692
2014
Q1 		$24.2M Buy
94,508
+63,884
+209% +$19.5M ﹤0.01% 1636
2013
Q4 		$6.07M Buy
30,624
+2,935
+11% +$522K ﹤0.01% 2474
2013
Q3 		$4.68M Buy
27,689
+1,337
+5% +$215K ﹤0.01% 2566
2013
Q2 		$4.68M Buy
+26,352
New +$3.73M ﹤0.01% 2497

State Street's LUMO Position: Q4 2024 in Review

State Street sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 11,237 shares — an estimated $43.5K sold.

State Street first reported a position in LUMO in Q2 2013 and held it in 41 quarters. The position peaked at $42.6M in Q1 2015. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

  • State Street reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • State Street sold 11,237 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $43.5K.
  • State Street first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 41 quarters.
  • State Street's Lumos Pharma, Inc. Common Stock position peaked at $42.6M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on State Street's 13F filing for Q4 2024, filed 14 Feb 2025.